Vocal fundamental frequency measures as a reflection of tumor response to chemotherapy in patients with advanced laryngeal cancer Journal Article

  

Authors:	Orlikoff, R. F.; Kraus, D. H.; Harrison, L. B.; Ho, M. L.; Gartner, C. J.
Article Title:	Vocal fundamental frequency measures as a reflection of tumor response to chemotherapy in patients with advanced laryngeal cancer
Abstract:	The fundamental frequency (F0) characteristics of 19 male patients with advanced laryngeal cancer, treated with cisplatin-based chemotherapy as part of a Larynx Preservation Protocol (LPP), were measured before each of three cycles of chemotherapy received before definitive radiotherapy (RT). In these select patients, for whom chemotherapy resulted in ≤50% decrease in the tumor bulk, it was found that mean F0 was essentially unaffected by the disease and did not change over the course of chemotherapy, although the cycle of their treatment could be differentiated by both speaking F0 variability (pitch sigma) and F0 perturbation (jitter). Although these measures failed to distinguish between those patients showing a complete response (CR) (no measurable disease) versus a partial (PR) (residual) tumor response at the primary disease site, the significant changes observed in both groups indicate that frequency variation measures could prove valuable in the documentation of tumor response to nonsurgical therapeutic intervention if the voice is directly affected. Additional assessment of 15 age- and disease-matched patients who showed minimal or no primary response to the chemotherapy showed no significant change in any of the frequency measures after one chemotherapy cycle, suggesting that vocal improvement seen in the successful chemotherapy patients was not due to postbiopsy healing or other systemic influence unassociated with tumor reduction.
Keywords:	adult; cancer chemotherapy; clinical article; controlled study; aged; middle aged; clinical trial; larynx carcinoma; carcinoma, squamous cell; laryngeal neoplasms; cisplatin; advanced cancer; antineoplastic agent; neoplasm staging; controlled clinical trial; drug response; carcinoma; voice; acoustics; larynx; phonation; speech acoustics; humans; human; male; article; acoustic voice measure; pitch perturbation; vocal fundamental frequency
Journal Title:	Journal of Voice
Volume:	11
Issue:	1
ISSN:	0892-1997
Publisher:	Mosby Elsevier
Date Published:	1997-01-01
Start Page:	33
End Page:	39
Language:	English
DOI:	10.1016/s0892-1997(97)80021-5
PUBMED:	9075174
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030951742&doi=10.1016%2fS0892-1997%2897%2980021-5&partnerID=40&md5=c9c07a0494e2128cf1b8d1c8cc775d27
Notes:	Article -- Export Date: 17 March 2017 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/108053